Navigation Links
Luminex Corporation Reports First Quarter 2012 Results
Date:4/30/2012

ercentages) Three Months EndedMarch 31,Variance20122011($)(%)(unaudited)System sales

$
,998$
7,679$
(681)-9%Consumable sales

11,90015,002(3,102)-21%Royalty revenue

8,2427,25698614%Assay revenue

17,2979,5847,71380%All other revenue

4,2903,75453614%$
48,727$
43,275$
5,45213%"Luminex delivered a solid financial and operating performance for the first quarter of 2012," said Patrick J. Balthrop, president and chief executive officer of Luminex.  "Our assay category showed excellent growth, driven by continued execution in our core assay franchises such as our xTAG® Cystic Fibrosis product line, growing demand outside the U.S. for our innovative xTAG Gastrointestinal Pathogen Panel (GPP), and a strong contribution from Luminex Madison. As expected, consumable revenue in the first quarter faced a difficult year-over-year comparison, yet grew 18% sequentially. In addition, we continue to grow our installed base at a healthy rate and are pleased to have expanded our distribution partners for our MAGPIX system with the addition of Bio-Rad Laboratories announced in early April." 

"Regarding new product initiatives, I am pleased to report that Luminex has received CE Marking for its NeoPlex4 assay and fully automated NeoPlex system. This product offering addresses a sizeable new market opportunity for Luminex and we are excited about the clear advantages offered to the public health lab customer," added Balthrop. "NeoPlex4 is another example of how Luminex provides advanced solutions and real value to our customers. With new assays like GPP, NeoPlex4 and the exciting portfolio from Luminex Madison, we are positioned for continued strong growth in the future," Balthrop concluded. 

"While we are pleased that both reportable segments achieved GAAP profitability in the first quarter of 2012, we experienced a decline in total operating income year-over-year primarily as a result of
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Luminex Corporation First Quarter Earnings Release Scheduled for April 30, 2012
2. Luminex Corporation Reports Fourth Quarter and Full Year 2011 Results
3. Luminex Corporation Vice President of Biodefense to Speak at DTRAS 2011 CBD S&T Conference
4. Luminex Corporation Reports Third Quarter 2011 Results
5. Luminex Corporation Receives Deloitte Technology Fast 500™ Award
6. Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
7. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
8. Luminex Corporation to Present at Upcoming Investment Conferences In September
9. Luminex Corporation Reports Second Quarter 2011 Results
10. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
11. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Minn. , Jan. 14, 2014   NuAire , a manufacturer ... to agreement with Hitachi Koki of Japan ... in North America . NuAire will utilize its ... and Canada to offer assistance in ...
(Date:1/14/2014)... Inc. , a privately held company pioneering the development ... related neurodegenerative disorders, announced today the relocation of its ... as of January 15, 2014 and expanded lease agreement ... Oligomerix, which is focused on the development ...
(Date:1/14/2014)... 14, 2014   Evidera , a leading provider of ... Center for Drug Evaluation and Research (CDER), U.S. Food ... guidance document for a patient-reported outcome (PRO) measure in ... Disease Tool [EXACT] for Measurement of Symptoms of Acute ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... and BEDMINSTER, N.J., Aug. 31 QRxPharma (ASX: QRX ... symposium at the 13th World Congress of Pain on ...  The symposium, titled "Dual Opioid Therapy: Changing the Paradigm" ... an immediate-release Dual Opioid product for moderate to severe ...
... plc (LSE: SHP, NASDAQ: SHPGY ), ... for inflammatory bowel disease (IBD) fellowships at leading medical ... in 2011 and will provide a year of training ... completed a fellowship in gastroenterology. "We are ...
Cached Medicine Technology:QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting 2QRxPharma to Sponsor Symposium at 13th World Congress on Pain Meeting 3Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide 2Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide 3
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... affects about one in five infants in the United ... the first several months after birth. Research into probiotic ... however, the April 1, 2014 issue of the ... a study, "Probiotics and Infant Colic," concluding that the ... infant colic did not reduce crying or fussing ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit ... issues, published a comprehensive review today examining the current ... virus. The review calls for improved global surveillance strategies ... the recent outbreak of Ebola in West Africa that ... countries of Guinea and Liberia. According to the ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
(Date:4/17/2014)... Meaningful long-term survival is possible for selected patients ... treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy, ... physicians at Wake Forest Baptist Medical Center. , ... experience with cytoreductive surgery and HIPEC, said lead ... 20 years, worth of patient data shows that ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:New MRSA superbug emerges in Brazil 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
... , SATURDAY, July 30 (HealthDay News) -- A new study ... users obsessively check their devices for e-mails, social media and ... the United States and Finland, and found that they checked ... less than 30 seconds and involves opening the screen lock ...
... , Alexandria, VA Tobacco related disease is a ... studies suggest that "alternative" tobacco products may have supplanted ... African Americans, according to new research published in the ... Neck Surgery. While the tobacco-related disease ...
... In an effort to reduce the radiation dose delivered by ... a comprehensive CT radiation dose reduction program which has allowed ... at their facility, according to an article in the August ... Radiology . CT is an essential tool ...
... approaches to dietary counseling for obesity are heavily rooted ... the ability to choose healthy foods and portion ... comfort foods. According to preventive medicine ... supports a new counseling approach that views obesity as ...
... FRIDAY, July 29 (HealthDay News) -- Any time there,s a ... at a youth camp in Norway, the shootings of a ... -- one question seems to ring clearer than others: Why ... disturbed and capable of committing deadly violence? Psychiatrists and ...
... , SATURDAY, July 30 (HealthDay News) -- Daughters have ... mothers, but there is no similar effect the other ... that teens may have more impact on their parents ... The study included 343 mother-daughter pairs who completed ...
Cached Medicine News:Health News:Smartphones Really Are Habit-Forming: Study 2Health News:Effects of tobacco use among rural African American young adult males 2Health News:Community hospital implements successful CT radiation dose reduction program 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 3Health News:Shootings Spark Interest in Spotting the Violence-Prone 2Health News:Shootings Spark Interest in Spotting the Violence-Prone 3
ApolipoproteinA-1 & B Calibrator...
CRP Calibrator...
Fructosamine controls level 3...
Drug controls sera available in three levels for the control of accuracy and percision for up to 18 analytes...
Medicine Products: